KEGG: vg:1261143
The Haemophilus phage HP1 Uncharacterized 23.2 kDa protein (also known as ORF1 or HP1p02) is encoded within the int-C1 intergenic region of the HP1 bacteriophage genome. It is located at position NC_001697.1 (1698..2315, complement) in the HP1 genome . The protein consists of 205 amino acids with a molecular weight of approximately 23,260 Da . Its genomic position between the integrase gene (int) and the C1 repressor gene suggests it may play a role in regulating the lysogenic-lytic cycle switch or site-specific integration mechanisms .
HP1 is a temperate bacteriophage belonging to the Myoviridae family that infects Haemophilus influenzae. The complete HP1 genome is 32,355 bp long with cohesive termini and encodes 41 probable protein coding segments organized into five plausible transcriptional units .
The recombinant Uncharacterized 23.2 kDa protein is typically expressed in E. coli expression systems with an N-terminal His-tag to facilitate purification . A standardized methodology includes:
Cloning and Expression: The full-length gene (1-205 aa) is cloned into an expression vector with a His-tag fusion and expressed in E. coli .
Purification Process:
Post-purification Processing:
An optimized protocol might include varying induction conditions, temperature, and expression duration to maximize yield while minimizing the formation of inclusion bodies, which can be problematic with membrane-associated proteins.
For optimal stability and activity maintenance, follow these research-validated handling and storage protocols:
Long-term Storage:
Reconstitution Protocol:
Working Storage:
Quality Control Measures:
Periodically verify protein integrity via SDS-PAGE
Consider activity assays if function becomes characterized
These conditions are designed to maintain structural integrity and prevent degradation or aggregation that could compromise experimental results .
To elucidate the function of this uncharacterized protein, a multi-dimensional experimental approach is recommended:
Genetic Modification Studies:
Generate HP1 phage variants with gene knockouts or mutations
Compare phenotypes (plaque morphology, lysis kinetics, host range)
Complementation studies with wild-type protein to confirm observed effects
Protein Localization Analysis:
Create fluorescently tagged versions for microscopy
Use subcellular fractionation and immunoblotting
Employ immunogold electron microscopy for high-resolution localization
Interaction Screening:
Perform pull-down assays with His-tagged protein
Utilize yeast two-hybrid or bacterial two-hybrid systems to identify binding partners
Validate interactions with co-immunoprecipitation and ELISA
Functional Assays:
Test for DNA binding using electrophoretic mobility shift assays
Assess membrane interaction via liposome binding or permeabilization assays
Examine effects on site-specific integration efficiency
Research on similar HP1 phage proteins has demonstrated the utility of these approaches. For example, studies on the HP1 lytic system characterized the lys and hol gene products using both in silico analysis and molecular cloning , providing a methodological template for investigating this protein.
Investigating protein-protein interactions for this uncharacterized protein requires a systematic approach combining in vitro and in vivo methods:
In Vitro Binding Assays:
Pull-down Assays: Immobilize the His-tagged protein on Ni-NTA resin and incubate with H. influenzae lysates or purified phage proteins
Surface Plasmon Resonance (SPR): Measure real-time binding kinetics between the protein and potential partners
Biolayer Interferometry: Determine association and dissociation rates with candidate interactors
In Vivo Interaction Methods:
Bacterial Two-Hybrid: Particularly appropriate for bacterial systems to identify interactions in a cellular context
Proximity-Based Labeling: Fusion with biotin ligase (BioID) or peroxidase (APEX) to identify proximal proteins
FRET/BRET Analysis: Monitor protein interactions using fluorescence or bioluminescence resonance energy transfer
Candidate Approach Based on Genomic Context:
Test interactions with HP1 integrase and C1 repressor proteins given the intergenic location
Examine binding to site-specific DNA sequences from the attachment region
Screen for interactions with host factors involved in phage integration
Validation Strategies:
Mutational analysis to identify critical interaction domains
Competition assays with peptides derived from binding regions
Co-expression studies to assess effects on function
Given the protein's location in the int-C1 intergenic region, priority should be given to testing interactions with integration machinery components and regulatory proteins controlling the lysogenic-lytic switch .
Although the three-dimensional structure of this protein has not been experimentally determined, sequence analysis and predictive modeling offer valuable insights into potential structural features:
Transmembrane Domain Prediction:
Secondary Structure Elements:
Structural Homology:
Functional Motif Prediction:
The protein could potentially contain DNA-binding motifs, given its location near regulatory regions
Alternatively, it might possess domains involved in protein-protein interactions with integration machinery components
These structural predictions should guide experimental approaches such as site-directed mutagenesis of key residues to test hypotheses about function and interaction capabilities.
Given its location in the int-C1 intergenic region, this protein may play a significant role in the site-specific integration mechanism of HP1 phage:
Attachment Site Context:
Integration Regulation:
The protein might serve as a regulatory factor controlling the timing or efficiency of integrase activity
It could potentially modulate the switch between integration (lysogeny) and excision (lytic cycle)
Architectural Function:
The protein could function as an architectural factor that helps organize the DNA-protein complex required for integration
It might facilitate the proper alignment of phage and bacterial attachment sites
Host Factor Interaction:
The protein might interact with host factors necessary for efficient integration
It could potentially serve as an adapter between phage components and host cellular machinery
Experimental approaches to test these hypotheses could include:
DNA binding assays using attachment site DNA sequences
In vitro integration assays with and without the purified protein
Construction of mutant phages lacking the gene to assess integration efficiency
Protein-protein interaction studies with the HP1 integrase
The search results indicate that specific DNA sequences within the attachment region are critical for HP1 integration , suggesting a complex machinery that might involve this uncharacterized protein.
Comparative analysis of this uncharacterized protein with similar proteins in related phages provides evolutionary and functional insights:
Phage Family Relationships:
Structural Conservation vs. Sequence Divergence:
Even with limited sequence similarity, structural conservation may exist
Domain architecture may be preserved while primary sequences diverge
Comparative Genomic Context:
Analysis of gene order and orientation in related phages can reveal conserved synteny
Similar proteins may be found in comparable regulatory regions across different phages
Horizontal Gene Transfer Assessment:
GC content analysis of the gene region compared to the rest of the genome
Codon usage bias examination to identify potential horizontal acquisition
Evolutionary Rate Analysis:
Comparative analysis of synonymous vs. non-synonymous substitution rates
Identification of conserved residues across divergent homologs, suggesting functional importance
A comprehensive study by Willi et al. identified 346 phages grouped in 52 clusters and 18 superclusters among Aggregatibacter and Haemophilus phages, demonstrating substantial diversity but also evolutionary relationships that could inform the function of this protein .
Understanding this uncharacterized protein could contribute significantly to phage-based antimicrobial development:
Therapeutic Phage Engineering:
Modification of this protein might alter phage host range or infection efficiency
Engineering conditional expression could create phages with controlled lysis timing
Target Identification:
If the protein interacts with specific host factors, these interactions could reveal novel antimicrobial targets
Blocking these interactions could potentially inhibit bacterial growth or virulence
Integration Control:
If involved in integration, modifying this protein could create non-integrating phages that remain lytic
Such engineered phages would be more suitable for phage therapy applications
Delivery System Development:
Membrane-interacting domains could be exploited to develop delivery systems for antimicrobial compounds
Fusion proteins combining this protein with antimicrobial peptides could enhance targeting
Phage Cocktail Optimization:
Understanding diversity among similar proteins across Haemophilus phages could inform the design of effective phage cocktails
Selection of phages with complementary integration mechanisms could reduce bacterial resistance development
Recent research has highlighted the potential of phages as therapeutic options against Haemophilus infections, with "putative lytic phages, especially phiKZ-like" being noted as promising candidates . Characterizing this protein could contribute to this emerging field by expanding our understanding of phage-host interactions.